Don’t miss the next Kahlert Institute for Addiction Medicine Seminar Series!
This engaging event showcases groundbreaking preclinical and clinical addiction research while fostering collaborative discussions to drive innovative solutions.
Wednesday, September 10, 2025 | 12:00 p.m. – 1:00 p.m.
HSF III, Room 1010
Professor of Neurobiology
Department of Psychiatry
Columbia University
Research Scientist VII
New York State Psychiatric Institute
October 8, 2025:
Assistant Professor, Psychiatry
University of Maryland School of Medicine
November 12, 2025: Aditi Ringwala, MD – Assistant Professor, Medicine, University of Maryland School of Medicine (Presentation title TBD)
December 10, 2025: Amy Janes, PhD – Investigator, National Institute on Drug Abuse (NIDA) Intramural Research Program (IRmP) (Presentation title TBD)
January 14, 2026: Malik Burnett, MD, MBA, MPH – Addiction Medicine Physician, UMMC Midtown Campus, Center for Addiction Medicine (Presentation title TBD)
February 11, 2026: Aaron Greenblatt, MD – Associate Professor, Family & Community Medicine, University of Maryland School of Medicine (Presentation title TBD)
March 4, 2026: Cassandra Gipson-Reichardt, PhD – Associate Professor, Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine (Presentation title TBD)
Mikhail Koffarnus, PhD – Associate Professor, Vice Chair of Research, Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine (Presentation title TBD)
April 8, 2026: Matthew Roesch, PhD – Professor, Department of Psychology, University of Maryland College Park (Presentation title TBD)
May 13, 2026: Eric J. Nestler, MD, PhD – Interim Dean of the Icahn School of Medicine, Nash Family Professor of Neuroscience, Mount Sinai; Chief Scientific Officer for the Mount Sinai Health System (Presentation title TBD)
March 12, 2025: Psycho-social and Behavioral Interventions
Marco Venniro, PhD – Associate Professor, Neurobiology, University of Maryland School of Medicine
Presentation Title: "The Role of Social Behavior on Substance Use Disorders"
Melanie Bennett, PhD – Professor, Psychiatry, University of Maryland School of Medicine; Division Director for the Division of Psychiatric Research Services
Presentation Title: "Supporting Behavior Change in Persons With Substance Use Disorders"
January 15, 2025: Substance Use in Pregnancy
Mary Kay Lobo, PhD – Professor, Neurobiology, University of Maryland School of Medicine; Co-Director, Center for Substance Use in Pregnancy; Associate Director, Kahlert Institute for Addiction Medicine
Presentation Title: "Using a Preclinical Model of Perinatal Fentanyl Exposure to Understand Long Lasting Biological Impacts"
Courtney Townsel, MD, MS – Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences, Director of Perinatal Research, University of Maryland School of Medicine
Presentation Title: "Opioid Use in Pregnancy: How Placental Transport and Metabolism Shape Neonatal Withdrawal Outcomes"
December 4, 2024: Aging and Addiction Research
Bethea "Annie" Kleykamp, PhD – Assistant Professor, Psychiatry, University of Maryland School of Medicine
Presentation Title: "Addressing Addiction Among Older Adults: A Forgotten Population"
Michy Kelly, PhD – Associate Professor, Neurobiology, University of Maryland School of Medicine
Presentation Title: "Consideration for Conduction Drug Studies in Aging Mice"
September 11, 2024: Cannabis Research
Joseph Cheer, PhD – Professor, Neurobiology, University of Maryland School of Medicine
Presentation Title: "Endogenous cannabinoids and the avoidance of fear"
Katrina Mark, MD, FACOG, FASAM – Associate Professor, Obstetrics, Gynecology and Reproductive Sciences, Chief of the Division of General Obstetrics & Gynecology, University of Maryland School of Medicine
Presentation Title: "Cannabis use in pregnancy: patterns, perceptions and problems"
February 22, 2024: Inaugural Seminar Series
Lorenzo Leggio, MD, PhD – Clinical Director, National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP)
Presentation Title: "Mind the Gut: Developing New Pharmacotherapies for Addiction"